Temprian Therapeutics is developing a new way to treat vitiligo by injecting DNA coding for a modified heat shock protein HSP70i to stop the autoimmune response
Nearly three quarters of the population carry genetic traits that can cause vitiligo, although it develops properly in only 0.5% to 4% of all people, depending on the region.
Source: A No-Nonsense Guide to Vitiligo by Yan Valle.
#vitiligo#treatment#body
Vitiligo is a prevelant skin disease, but nearly 100 million people suffering from this condition are seemingly invisible to the healthcare systems of almost every country.
Source: A No-Nonsense Guide to Vitiligo by Yan Valle.
#vitiligo#treatment#body
Vitiligo is a systemic disease affecting the largest body organ and other vital systems. Tip: Start vitiligo treatment as soon as possible, ideally within the first month or two of spotting natural color fade.
Source: A No-Nonsense Guide to Vitiligo by Yan Valle.
When the first sign of vitiligo appeared on Kimberly's chin in 2013, she had the same reaction as many patients. -- See her inspiring story at https://t.co/uKywVekhIb.
Have you seen the community dedicated to parents of children with vitiligo in Vitiligo Support International? --Take a moment to see it here! https://t.co/ojTRZ2suzA
Professor Caroline Le Poole pitching on modified HSP70i based treatment of vitiligo for 150 pharmaceutical investors today at the S2S conference. Out of 176 companies 12 made it to the podium; Temprian was one of them.
Scientists and researchers are working on new treatments for vitiligo, and some of them appear very promising. There are already several therapies and methods that currently exist which you may want to consider if you suffer from vitiligo. #vitiligo
Photo Credit: Andrea Lopez
Vitiligo creates white patches that can cause people to hide their skin. It is a disease that can scar you deeply, interfering with all aspects of social and professional life. #vitiligo#TemprianTherapeutics#ClinicalTrials
Photo Credit: Andrea Lopez
We are developing a new way to treat vitiligo by injecting DNA coding for a modified heat shock protein HSP70i to stop the autoimmune response at the outset. #vitiligo#clinicaltrials
Photo Credit: @FotoCoqui
Caroline Le Poole will be presenting HSP70I, based treatment of #vitiligo in this year's #Science2Startup! This event connects therapeutics researchers from top academic institutions with biotech investors. Hosted by @atlasventure. For more info visit https://t.co/5LWXGRoLqB.
"In vitiligo, patches of skin lose their pigmentation when the pigment producing cells, the 'melanocytes' are attacked and destroyed." See full article at https://t.co/5Bwgloo0hw.